FDA Approves Voceryq for Recurrent Respiratory Papillomatosis
The FDA granted accelerated approval to Voceryq, the first plasmid DNA-based immunotherapy approved in the US for adult patients with recurrent respiratory papillomatosis (RRP).
Breaking News
🔥 TOP 5 STORIES
Hantavirus Outbreak Highlights Person-to-Person Transmission Risks
A recent cruise ship outbreak of the Andes strain underscores the potential for silent spread and severe respiratory complications in travel networks.
The Latest News Delivered Directly to Your Inbox!
Join our mailing list to receive the latest news, information, and updates on the Respiratory Health.RT: The Digital Edition
Medtech & Pharma Breakthroughs
Mindray Launches SV70 Noninvasive Ventilator
The SV70 provides noninvasive ventilation and high-flow therapy while maintaining compatibility with existing hospital accessories.
Combatting Infectious Diseases
COPD & Asthma Updates
National Microbiome Plan to Prevent Chronic Disease
A new proposal calls for federal investment to study how early microbial disruptions contribute to conditions like asthma, obesity, and allergies.
